Literature DB >> 29497927

Recent Advances in Understanding Bisphosphonate Effects on Bone Mechanical Properties.

Matthew R Allen1,2,3.   

Abstract

PURPOSE OF THE REVIEW: Bisphosphonates have well-established effects on suppressing bone resorption and slowing bone loss, yet the effects on bone mechanical properties are less clear. We review recent data from pre-clinical and clinical experiments that assessed mechanical properties of bisphosphonate-treated specimens. RECENT
FINDINGS: Pre-clinical work has utilized new techniques to show reduced fatigue life and transfer of stress from the mineral to collagen. Several notable studies have examined mechanical properties of tissue from patients treated with bisphosphonates with mixed results. Pre-clinical data suggest effects on mechanics may be independent of remodeling suppression. The direct effect of bisphosphonates on bone mechanics remains unclear but recent work has set a solid foundation for the coming years.

Entities:  

Keywords:  Anti-remodeling; Atypical fracture; Biomechanics; Remodeling suppression; Zoledronate

Mesh:

Substances:

Year:  2018        PMID: 29497927      PMCID: PMC6263169          DOI: 10.1007/s11914-018-0430-3

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  27 in total

1.  Zoledronate treatment has different effects in mouse strains with contrasting baseline bone mechanical phenotypes.

Authors:  M W Aref; E M B McNerny; D Brown; K J Jepsen; M R Allen
Journal:  Osteoporos Int       Date:  2016-07-20       Impact factor: 4.507

Review 2.  Preclinical Models for Skeletal Research: How Commonly Used Species Mimic (or Don't) Aspects of Human Bone.

Authors:  Matthew R Allen
Journal:  Toxicol Pathol       Date:  2017-09-25       Impact factor: 1.902

3.  Proposed pathogenesis for atypical femoral fractures: lessons from materials research.

Authors:  B Ettinger; D B Burr; R O Ritchie
Journal:  Bone       Date:  2013-02-16       Impact factor: 4.398

Review 4.  Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-10-01       Impact factor: 6.741

5.  Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates.

Authors:  J Ward; C Wood; K Rouch; D Pienkowski; H H Malluche
Journal:  Osteoporos Int       Date:  2016-07-22       Impact factor: 4.507

Review 6.  Bisphosphonates: a review of their pharmacokinetic properties.

Authors:  J H Lin
Journal:  Bone       Date:  1996-02       Impact factor: 4.398

7.  The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate.

Authors:  Devendra Bajaj; Joseph R Geissler; Matthew R Allen; David B Burr; J C Fritton
Journal:  Bone       Date:  2014-04-01       Impact factor: 4.398

8.  Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions.

Authors:  Elizabeth A Zimmermann; Eric Schaible; Bernd Gludovatz; Felix N Schmidt; Christoph Riedel; Matthias Krause; Eik Vettorazzi; Claire Acevedo; Michael Hahn; Klaus Püschel; Simon Tang; Michael Amling; Robert O Ritchie; Björn Busse
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

9.  Alendronate treatment alters bone tissues at multiple structural levels in healthy canine cortical bone.

Authors:  Claire Acevedo; Hrishikesh Bale; Bernd Gludovatz; Amy Wat; Simon Y Tang; Mingyue Wang; Björn Busse; Elizabeth A Zimmermann; Eric Schaible; Matthew R Allen; David B Burr; Robert O Ritchie
Journal:  Bone       Date:  2015-08-05       Impact factor: 4.398

10.  Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.

Authors:  M Saito; S Mori; T Mashiba; S Komatsubara; K Marumo
Journal:  Osteoporos Int       Date:  2008-03-29       Impact factor: 5.071

View more
  6 in total

1.  Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels.

Authors:  B Cardozo; E Karatza; V Karalis
Journal:  Osteoporos Int       Date:  2021-05-17       Impact factor: 4.507

2.  Ex vivo cortical porosity and thickness predictions at the tibia using full-spectrum ultrasonic guided-wave analysis.

Authors:  Johannes Schneider; Gianluca Iori; Donatien Ramiandrisoa; Maroua Hammami; Melanie Gräsel; Christine Chappard; Reinhard Barkmann; Pascal Laugier; Quentin Grimal; Jean-Gabriel Minonzio; Kay Raum
Journal:  Arch Osteoporos       Date:  2019-02-20       Impact factor: 2.617

3.  Anthranilic Acid Inhibitors of Undecaprenyl Pyrophosphate Synthase (UppS), an Essential Enzyme for Bacterial Cell Wall Biosynthesis.

Authors:  Marko Jukič; Kaja Rožman; Matej Sova; Hélène Barreteau; Stanislav Gobec
Journal:  Front Microbiol       Date:  2019-01-14       Impact factor: 5.640

4.  Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report.

Authors:  Thiago Quadrante Freitas; André Silva Franco; Rosa Maria Rodrigues Pereira
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

5.  Long-term bisphosphonate treatment coupled with ovariectomy in mice provokes deleterious effects on femoral neck fracture pattern and modifies tibial shape.

Authors:  Samuel Monzem; Rafael Y Ballester; Behzad Javaheri; Blandine Poulet; Dábila A Sônego; Andrew A Pitsillides; Roberto L Souza
Journal:  Bone Jt Open       Date:  2020-09-01

6.  Nanoscale mechanisms in age-related hip-fractures.

Authors:  Shaocheng Ma; En Lin Goh; Tabitha Tay; Crispin C Wiles; Oliver Boughton; John H Churchwell; Yong Wu; Angelo Karunaratne; Rajarshi Bhattacharya; Nick Terrill; Justin P Cobb; Ulrich Hansen; Richard L Abel
Journal:  Sci Rep       Date:  2020-08-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.